These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 14753416)
1. Calcineurin and cyclophilin D are differential targets of neuroprotection by immunosuppressants CsA and FK506 in ischemic brain damage. Uchino H; Ishii N; Shibasaki F Acta Neurochir Suppl; 2003; 86():105-11. PubMed ID: 14753416 [TBL] [Abstract][Full Text] [Related]
2. Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition. Uchino H; Minamikawa-Tachino R; Kristián T; Perkins G; Narazaki M; Siesjö BK; Shibasaki F Neurobiol Dis; 2002 Aug; 10(3):219-33. PubMed ID: 12270685 [TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat. Yoshimoto T; Uchino H; He QP; Li PA; Siesjö BK Brain Res; 2001 Apr; 899(1-2):148-58. PubMed ID: 11311876 [TBL] [Abstract][Full Text] [Related]
4. Cellular signaling mechanisms for stimulation of growth hormone secretion and growth hormone primary transcripts by immunosuppressant agents, FK506 and cyclosporin A, in cultured rat pituitary cells. Ohye H; Sato M; Murao K; Matsubara S; Tokuda M; Takahara J Neuroimmunomodulation; 1998; 5(6):309-17. PubMed ID: 9762012 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of arachidonic acid release by cytosolic phospholipase A2 is involved in the antiapoptotic effect of FK506 and cyclosporin a on astrocytes exposed to simulated ischemia in vitro. Gabryel B; Chalimoniuk M; Stolecka A; Waniek K; Langfort J; Malecki A J Pharmacol Sci; 2006 Sep; 102(1):77-87. PubMed ID: 16990701 [TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structure and actions of immunosuppressants and their immunophilins. Braun W; Kallen J; Mikol V; Walkinshaw MD; Wüthrich K FASEB J; 1995 Jan; 9(1):63-72. PubMed ID: 7529736 [TBL] [Abstract][Full Text] [Related]
7. Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat. Uchino H; Elmér E; Uchino K; Li PA; He QP; Smith ML; Siesjö BK Brain Res; 1998 Nov; 812(1-2):216-26. PubMed ID: 9813336 [TBL] [Abstract][Full Text] [Related]
8. A novel neuroprotective compound FR901459 with dual inhibition of calcineurin and cyclophilins. Uchino H; Morota S; Takahashi T; Ikeda Y; Kudo Y; Ishii N; Siesjö BK; Shibasaki F Acta Neurochir Suppl; 2006; 96():157-62. PubMed ID: 16671446 [TBL] [Abstract][Full Text] [Related]
9. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Bram RJ; Hung DT; Martin PK; Schreiber SL; Crabtree GR Mol Cell Biol; 1993 Aug; 13(8):4760-9. PubMed ID: 7687744 [TBL] [Abstract][Full Text] [Related]
10. FK506 and the role of immunophilins in nerve regeneration. Gold BG Mol Neurobiol; 1997 Dec; 15(3):285-306. PubMed ID: 9457703 [TBL] [Abstract][Full Text] [Related]
11. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin. Bell A; Wernli B; Franklin RM Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696 [TBL] [Abstract][Full Text] [Related]
12. A proposed molecular model for the interaction of calcineurin with the cyclosporin A-cyclophilin A complex. Ivery MT Bioorg Med Chem; 1999 Jul; 7(7):1389-402. PubMed ID: 10465413 [TBL] [Abstract][Full Text] [Related]
13. Neural roles of immunophilins and their ligands. Sabatini DM; Lai MM; Snyder SH Mol Neurobiol; 1997 Oct; 15(2):223-39. PubMed ID: 9396011 [TBL] [Abstract][Full Text] [Related]
14. Effects of immunosuppressants, calcineurin inhibition, and blockade of endoplasmic reticulum calcium channels on free fatty acid efflux from the ischemic/reperfused rat cerebral cortex. Phillis JW; Diaz FG; O'Regan MH; Pilitsis JG Brain Res; 2002 Dec; 957(1):12-24. PubMed ID: 12443975 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of neuroprotective action of immunosuppressants--facts and hypotheses. Kaminska B; Gaweda-Walerych K; Zawadzka M J Cell Mol Med; 2004; 8(1):45-58. PubMed ID: 15090260 [TBL] [Abstract][Full Text] [Related]
16. Nitric-oxide-synthase-mediated cyclic guanosine monophosphate production in neonatal rat cerebellar prisms is resistant to calcineurin inhibition. Macleod MR; Butcher SP Neurosci Lett; 2002 Mar; 322(1):41-4. PubMed ID: 11958839 [TBL] [Abstract][Full Text] [Related]
17. Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin. Jin L; Harrison SC Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13522-6. PubMed ID: 12357034 [TBL] [Abstract][Full Text] [Related]
18. Immunophilin regulation of neurotransmitter release. Steiner JP; Dawson TM; Fotuhi M; Snyder SH Mol Med; 1996 May; 2(3):325-33. PubMed ID: 8784785 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the protective effects of cyclosporin a and FK506 on abnormal cytosolic and mitochondrial Ca²⁺ dynamics during ischemia and exposure to high glutamate concentration in mouse brain slice preparations. Yokoyama T; Tanoue T; Hasegawa E; Ikeda Y; Ohta S; Omi A; Kudo Y; Uchino H J Pharmacol Sci; 2012; 120(3):228-40. PubMed ID: 23099321 [TBL] [Abstract][Full Text] [Related]
20. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Sharkey J; Butcher SP Nature; 1994 Sep; 371(6495):336-9. PubMed ID: 7522303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]